Trademark/Service Mark Application, Principal Register
PTO- 1478
Approved for use through 02/28/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Qiagen Sciences, LLC
*MAILING ADDRESS
19300 Germantown Road
*CITY
Germantown
*STATE
(Required for U.S. applicants)
Maryland
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
20874
*EMAIL ADDRESS
XXXX
WEBSITE ADDRESS
http://www.qiagen.com/us/
LEGAL ENTITY INFORMATION
TYPE
limited liability company
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY WHERE LEGALLY ORGANIZED
Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
001
*IDENTIFICATION
Chemical, biochemical and biotechnological products for industrial and scientific purposes, namely, diagnostic preparations except for human
or veterinary medical purposes; non-medical reagents, enzymes and buffer solutions for scientific and/or medical research use; non-medical reagents, enzymes and buffer solutions for molecular biology
applications; non-medical reagents, enzymes and buffer solutions for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating,
sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for
nucleic acid purification, enrichment, amplification and sequencing; kits comprising chemicals for sample preparation, modification and manipulation of cells; kits comprising chemicals for marking,
separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in
particular nucleic acids of biological or biochemical sample material; kits comprising reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and
sequencing.
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the
submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
INTERNATIONAL CLASS
005
*IDENTIFICATION
Diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic preparations for humans for medical
purposes; preparations for medical and veterinary purposes, in particular diagnostics, for sample preparation, modification and manipulation of cells and for marking, separating, isolating,
purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes
and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing; chemical, biochemical and biotechnological preparations for medical and veterinary purposes, in
particular reagents, enzymes and buffer solutions for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for
the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid
purification, enrichment, amplification and sequencing; kits containing preparations for medical and veterinary diagnostic purposes, in particular for sample preparation, modification and
manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and
biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing.
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the
submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
INTERNATIONAL CLASS
*IDENTIFICATION
Scientific apparatuses, instruments and devices, as well as their parts and components included in this class; software for use in scientific
and medical research; scientific apparatuses, instruments and devices, software in the area of analysis of nucleic acids, in particular sequencing of nucleic acids.
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the
submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
ATTORNEY INFORMATION
NAME
Randolph E. Digges, III
ATTORNEY DOCKET NUMBER
GIL-50569
ATTORNEY BAR MEMBERSHIP NUMBER
XXX
YEAR OF ADMISSION
XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY
XX
FIRM NAME
Rankin, Hill & Clark, LLP
STREET
P.O. Box 1150
CITY
Bonita Springs
STATE
Florida
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
ZIP/POSTAL CODE
34133-1150
PHONE
216-566-9700
FAX
216-566-9711
EMAIL ADDRESS
75628@rankinhill.com
OTHER APPOINTED ATTORNEY
David E. Spaw, Mark E. Bandy, Erik J. Overberger, Jonathan A. Withrow, Gregory S. Vickers, Christopher J. Korff, Samir S. Khoury, Robert A.
Sidoti, Kazuto Ishihara, Kevin M. Goodman, Maria T. Ianiro, Matthew T. Waters, Aashish Chawla, Jack D. Gau, Pam L. Granger, Michael L. Centa
CORRESPONDENCE INFORMATION
NAME
Randolph E. Digges, III
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE
75628@rankinhill.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES)
NOT PROVIDED
FEE INFORMATION
APPLICATION FILING OPTION
TEAS Standard
NUMBER OF CLASSES
3
APPLICATION FOR REGISTRATION PER CLASS
350
*TOTAL FEES DUE
1050
*TOTAL FEES PAID
1050
SIGNATURE INFORMATION
SIGNATURE
/Randolph E. Digges, III/
SIGNATORY'S NAME
Randolph E. Digges, III
SIGNATORY'S POSITION
Attorney of record, Ohio bar member
SIGNATORY'S PHONE NUMBER
216-566-9700
DATE SIGNED
02/28/2021
SIGNATURE METHOD
Signed directly within the form
PTO- 1478
Approved for use through 02/28/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
Serial Number:90551592
Filing Date:02/28/2021
To the Commissioner for Trademarks:
MARK: FastSelect (Standard Characters, see mark)
The literal element of the mark consists of FastSelect. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Qiagen Sciences, LLC, a limited liability company legally organized under the laws of Delaware, having an address of
19300 Germantown Road
Germantown, Maryland 20874
United States
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 001: Chemical, biochemical and biotechnological products for industrial and scientific purposes, namely, diagnostic preparations except for human or veterinary medical
purposes; non-medical reagents, enzymes and buffer solutions for scientific and/or medical research use; non-medical reagents, enzymes and buffer solutions for molecular biology applications;
non-medical reagents, enzymes and buffer solutions for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for
the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid
purification, enrichment, amplification and sequencing; kits comprising chemicals for sample preparation, modification and manipulation of cells; kits comprising chemicals for marking, separating,
isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic
acids of biological or biochemical sample material; kits comprising reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing.
Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of
priority based on European Union Trademark - EUTM application number 018302914, filed 09/04/2020.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the
foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
International Class 005: Diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic preparations for humans for medical purposes; preparations for
medical and veterinary purposes, in particular diagnostics, for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing
and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid
purification, enrichment, amplification and sequencing; chemical, biochemical and biotechnological preparations for medical and veterinary purposes, in particular reagents, enzymes and buffer
solutions for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in
particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification
and sequencing; kits containing preparations for medical and veterinary diagnostic purposes, in particular for sample preparation, modification and manipulation of cells and for marking, separating,
isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents,
enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing.
Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of
priority based on European Union Trademark - EUTM application number 018302914, filed 09/04/2020.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the
foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
International Class _______: Scientific apparatuses, instruments and devices, as well as their parts and components included in this class; software for use in scientific and medical research;
scientific apparatuses, instruments and devices, software in the area of analysis of nucleic acids, in particular sequencing of nucleic acids.
Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of
priority based on European Union Trademark - EUTM application number 018302914, filed 09/04/2020.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the
foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
For informational purposes only, applicant's website address is: http://www.qiagen.com/us/
The owner's/holder's proposed attorney information: Randolph E. Digges, III. Other appointed attorneys are David E. Spaw, Mark E. Bandy, Erik J. Overberger, Jonathan A. Withrow, Gregory S. Vickers,
Christopher J. Korff, Samir S. Khoury, Robert A. Sidoti, Kazuto Ishihara, Kevin M. Goodman, Maria T. Ianiro, Matthew T. Waters, Aashish Chawla, Jack D. Gau, Pam L. Granger, Michael L.
Centa. Randolph E. Digges, III of Rankin, Hill & Clark, LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
P.O. Box 1150
Bonita Springs, Florida 34133-1150
United States
216-566-9700(phone)
216-566-9711(fax)
75628@rankinhill.com
The docket/reference number is GIL-50569.
Randolph E. Digges, III submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or
any U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
Randolph E. Digges, III
PRIMARY EMAIL FOR CORRESPONDENCE: 75628@rankinhill.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $1050 has been submitted with the application, representing payment for 3 class(es).
Declaration
Declaration Signature
Signature: /Randolph E. Digges, III/ Date: 02/28/2021
Signatory's Name: Randolph E. Digges, III
Signatory's Position: Attorney of record, Ohio bar member
Signatory's Phone Number: 216-566-9700
Signature method: Signed directly within the form
Payment Sale Number: 90551592
Payment Accounting Date: 03/01/2021
Serial Number: 90551592
Internet Transmission Date: Sun Feb 28 20:47:40 ET 2021
TEAS Stamp: USPTO/BAS-XXX.XX.XX.XX-20210228204740869
206-90551592-7709a1635efff5b16c9d2abb076
81d5a342c4b6687fb76bfe3e3f74f62e7f63351-
CC-47390294-20210228204006350096